Oxytrol For Women


Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 67.0%
Hypertonic Bladder 7.1%
Pollakiuria 4.7%
Hypertension 3.2%
Incontinence 3.1%
Urinary Incontinence 3.1%
Nocturia 1.7%
Blood Pressure 1.2%
Diabetes Mellitus 1.1%
Hypothyroidism 1.1%
Blood Cholesterol Increased 1.0%
Micturition Urgency 0.8%
Gastrooesophageal Reflux Disease 0.7%
Urge Incontinence 0.7%
Atrial Fibrillation 0.6%
Stress Urinary Incontinence 0.6%
Depression 0.6%
Blood Cholesterol 0.5%
Thyroid Disorder 0.5%
Arthritis 0.4%
Drug Ineffective 35.9%
Product Quality Issue 9.5%
Drug Effect Decreased 8.0%
Product Adhesion Issue 7.5%
Wrong Technique In Drug Usage Process 4.7%
Pruritus 4.2%
Application Site Pruritus 3.7%
Rash 3.7%
Application Site Erythema 3.5%
Off Label Use 2.7%
Skin Irritation 2.2%
Erythema 2.0%
Dry Mouth 1.7%
Product Packaging Issue 1.7%
Vision Blurred 1.7%
Headache 1.5%
Somnolence 1.5%
Urinary Incontinence 1.5%
Application Site Irritation 1.2%
Application Site Rash 1.2%
Secondary
Product Used For Unknown Indication 50.0%
Hypertonic Bladder 9.2%
Urinary Incontinence 5.3%
Pollakiuria 4.4%
Hypertension 3.4%
Hypothyroidism 3.4%
Incontinence 3.4%
Micturition Urgency 3.4%
Blood Cholesterol Increased 2.9%
Nocturia 2.9%
Stress Urinary Incontinence 2.9%
Urge Incontinence 1.9%
Atrial Fibrillation 1.5%
Blood Triglycerides Increased 1.0%
Chronic Obstructive Pulmonary Disease 1.0%
Rheumatoid Arthritis 1.0%
Thyroid Disorder 1.0%
Cardiac Disorder 0.5%
Gastric Disorder 0.5%
Gastrooesophageal Reflux Disease 0.5%
Drug Ineffective 30.6%
Product Quality Issue 11.1%
Drug Effect Decreased 8.3%
Pruritus 5.6%
Urinary Incontinence 5.6%
Application Site Pruritus 2.8%
Application Site Vesicles 2.8%
Blood Pressure Increased 2.8%
Dizziness 2.8%
Overdose 2.8%
Pain 2.8%
Product Adhesion Issue 2.8%
Product Packaging Issue 2.8%
Rash 2.8%
Skin Burning Sensation 2.8%
Skin Exfoliation 2.8%
Therapeutic Response Decreased 2.8%
Vertigo 2.8%
Wrong Technique In Drug Usage Process 2.8%

Drug Data